Sangamo Therapeutics (SGMOQ) Return on Assets (2011 - 2025)

Sangamo Therapeutics' Return on Assets history runs 15 years deep, the most recent figure standing at 0.02% for Q4 2025.

• On a quarterly basis, Return on Assets fell 1.0% year-over-year to 0.02% in Q4 2025; TTM through Dec 2025 was 0.02%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.02%, down 1.0% from the prior year.
• Return on Assets retreated to 0.02% in Q4 2025 per SGMOQ's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2021 and bottomed at 0.02% in Q2 2024.
• The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
• Across the five-year window, Return on Assets decreased 2 bps in 2024 and climbed 2 bps in 2025, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2021, then plunged by 39 bps to 0.0% in 2022, then slumped by 303 bps to 0.01% in 2023, then soared by 31 bps to 0.01% in 2024, then slumped by 80 bps to 0.02% in 2025.
• Per Business Quant, the three latest SGMOQ Return on Assets figures stand at 0.02% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).